Regulation 10 Amendment of regulation 21 (clinical trials conducted in third countries)I1
United Kingdom
(1)
Regulation 21 is amended as follows.
(2)
In the heading, for “third countries” substitute “ countries other than the United Kingdom ”.
(3)
In paragraph (1), for “a third” substitute “ another ”.
Annotations
Commencement
- I1
Reg. 10 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1